Package 51672-4063-1

{"route": ["TOPICAL"], "spl_id": "3225bf24-833e-4d6a-bfe8-08df4fecb218", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["U3P01618RT"], "rxcui": ["310379", "310380"], "spl_set_id": ["1b2f6145-b338-42ed-88a7-f4da65c59164"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (51672-4063-1)  / 10 mL in 1 BOTTLE", "package_ndc": "51672-4063-1", "marketing_start_date": "20031105"}], "brand_name": "Fluorouracil", "product_id": "51672-4063_3225bf24-833e-4d6a-bfe8-08df4fecb218", "dosage_form": "SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "51672-4063", "generic_name": "Fluorouracil", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluorouracil", "active_ingredients": [{"name": "FLUOROURACIL", "strength": "50 mg/mL"}], "application_number": "ANDA076526", "marketing_category": "ANDA", "marketing_start_date": "20031105", "listing_expiration_date": "20261231"}